Ortsbeo IV 500 contains efanethoctocog alfa, a recombinant Factor VIII concentrate approved for adults and children with hemophilia A. Developed by Sanofi, this injectable drug (YJ code: 6343459D2024) is supplied as a 500 IU bottle with dissolving solution.
Ortsbeo IV 500
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).